Valinor Pharma (acquired by Grünenthal) Revenue

Pharmaceutical Manufacturing • Chicago, Illinois, United States • 21-50 Employees

Valinor Pharma (acquired by Grünenthal) revenue & valuation

Annual revenue	$3,079,980
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues	$9,900,000
Total funding	No funding

Key Contacts at Valinor Pharma (acquired by Grünenthal)

Rosemary Amato

Sr. Director, Market Access, Valinor Pharma, Llc

Jackie Prince

Associate Director, Pharmacovigilance

Company overview

Headquarters	Chicago, Illinois, United States
Phone number	+18332330115
Website	valinorrx.com
NAICS	3254
Employees	21-50
Socials

Valinor Pharma (acquired by Grünenthal) Email Formats

Valinor Pharma (acquired by Grünenthal) uses 3 email formats. The most common is {first name}{last name} (e.g., johndoe@valinorrx.com), used 55% of the time.

Format	Example	Percentage
{first name}{last name}	johndoe@valinorrx.com	55%
{first initial}{last name}	jdoe@valinorrx.com	40%
{last name}{last name}	doedoe@valinorrx.com	5%

About Valinor Pharma (acquired by Grünenthal)

Valinor Pharma is focused on innovative commercialization of medicines that not only bring meaningful benefit to patients but also ensure that when a healthcare provider prescribes them to the patients they serve, their patients are able to get them easily and affordably. To learn more about Valinor, our products, or to discuss partnership opportunities, please visit www.valinorrx.com.

Employees by Management Level

Total employees: 21-50

Seniority

Employees

Manager

Entry

Vice President

Employees by Department

Valinor Pharma (acquired by Grünenthal) has 28 employees across 5 departments.

Departments

Number of employees

Funding Data

Valinor Pharma (acquired by Grünenthal) has never raised funding before.

Valinor Pharma (acquired by Grünenthal) Tech Stack

Discover the technologies and tools that power Valinor Pharma (acquired by Grünenthal)'s digital infrastructure, from frameworks to analytics platforms.

Amazon Web Services

PaaS

jQuery

JavaScript libraries

Google Tag Manager

Tag managers

HSTS

Security

GSAP

JavaScript frameworks

PWA

Miscellaneous

Google Analytics

Analytics

Netlify

CDN

Microsoft 365

Frequently asked questions

Valinor Pharma (acquired by Grünenthal) is located in Chicago, Illinois, US.

You can reach Valinor Pharma (acquired by Grünenthal) at +18332330115.

Valinor Pharma (acquired by Grünenthal) generates an estimated annual revenue of $3,079,980. This revenue figure reflects the company's market position and business performance in its industry.

Valinor Pharma (acquired by Grünenthal) has an estimated valuation of $9,900,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Valinor Pharma (acquired by Grünenthal) has approximately 21-50 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contacts at Valinor Pharma (acquired by Grünenthal)

Rosemary Amato

Sr. Director, Market Access, Valinor Pharma, Llc

Jackie Prince

Associate Director, Pharmacovigilance

4.8

40,000 users